Literature DB >> 15047618

Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells.

Satsuki Miyazaki1, Eiji Yamato, Jun-ichi Miyazaki.   

Abstract

Embryonic stem (ES) cells can differentiate into many cell types. Recent reports have shown that ES cells can differentiate into insulin-producing cells. However, the differentiation is not efficient enough to produce insulin-secreting cells for future therapeutic use. Pdx-1, a homeodomain-containing transcription factor, is a crucial regulator for pancreatic development. We established an ES cell line in which exogenous pdx-1 expression was precisely regulated by the Tet-off system integrated into the ROSA26 locus. Using this cell line, we examined the effect of pdx-1 expression during in vitro differentiation via embryoid body formation. The results showed that pdx-1 expression clearly enhanced the expression of the insulin 2, somatostatin, Kir6.2, glucokinase, neurogenin3, p48, Pax6, PC2, and HNF6 genes in the resulting differentiated cells. Immunohistochemical examination also revealed that insulin was highly produced in most of the differentiated ES cells. Thus, exogenous expression of pdx-1 should provide a promising approach for efficiently producing insulin-secreting cells from human ES cells for future therapeutic use in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047618     DOI: 10.2337/diabetes.53.4.1030

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

Review 1.  In vivo imaging of embryonic stem cell therapy.

Authors:  Han Jiang; Zhen Cheng; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-24       Impact factor: 9.236

2.  Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene.

Authors:  Zahra Niki Boroujeni; Ahmad Aleyasin
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 3.  Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.

Authors:  Hideaki Kaneto; Naoto Katakami; Munehide Matsuhisa; Taka-aki Matsuoka
Journal:  Mediators Inflamm       Date:  2010-02-16       Impact factor: 4.711

Review 4.  The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.

Authors:  D Gerace; R Martiniello-Wilks; B A O'Brien; A M Simpson
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

5.  Onecut transcription factors in development and disease.

Authors:  Peter A Kropp; Maureen Gannon
Journal:  Trends Dev Biol       Date:  2016

6.  In vitro pancreas duodenal homeobox-1 enhances the differentiation of pancreatic ductal epithelial cells into insulin-producing cells.

Authors:  Tao Liu; Chun-You Wang; Feng Yu; Shan-Miao Gou; He-Shui Wu; Jiong-Xin Xiong; Feng Zhou
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

7.  Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Authors:  Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

8.  Stem cell therapy to treat diabetes mellitus.

Authors:  Chee Gee Liew; Peter W Andrews
Journal:  Rev Diabet Stud       Date:  2009-02-10

Review 9.  Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells.

Authors:  Dong Hyeon Lee; Hyung Min Chung
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

10.  In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells.

Authors:  A Eshpeter; J Jiang; M Au; R V Rajotte; K Lu; J S Lebkowski; A S Majumdar; G S Korbutt
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.